波兰的监管制度涉及到ATMP医院豁免
Jan Pachocki1, Frances Verter2
1Consultant, Warsaw, Poland.
Frontiers in immunology
|May 28, 2024
概括
波兰 波兰 波兰 波兰
科学领域:
- 监管科学 监管科学
- 卫生政策 卫生政策
- 生物技术是生物技术.
背景情况:
- 根据医院豁免 (ATMP-HE) 对先进治疗药物 (ATMP) 的监管框架对于患者获得创新治疗至关重要.
- 波兰对ATMP-HE法规的实施在2018年至2023年之间发生了显著的发展.
- 介质细胞干细胞 (MSC) 是波兰主要使用的ATMP-HE疗法.
研究的目的:
- 阐明波兰ATMP-HE目前的监管环境.
- 分析波兰ATMP-HE法规对制造商,医生和患者的影响.
- 将波兰的ATMP-HE实践与其他欧盟成员国进行比较.
主要方法:
- 翻译和分析有关ATMP-HE的波兰相关立法.
- 利益相关者分析检查制造商,医生和患者的观点.
- 在欧盟背景下对波兰的ATMP-HE系统进行比较评估.
主要成果:
- 波兰ATMP-HE法规从2018年至2023年进行了实质性修订.
- 介质细胞干细胞 (MSC) 疗法占波兰ATMP-HE治疗的大部分.
- 波兰的ATMP-HE实施符合欧盟的一般做法,但在医疗保健资金方面面临挑战.
结论:
- 由于人均支出较低,波兰的ATMP-HE需要在国家医疗保健系统之外获得资金.
- 该系统为未满足的医疗需求提供实验性疗法的能力正面临压力.
- 平衡利益相关者的利益是实现ATMP-HE立法最初意图的关键.
关键词:
先进疗法药物 (ATMPs) 是指先进疗法药物.细胞和基因疗法 (CGT)医院豁免 (HE) 的情况.介质细胞 stromal 细胞 (MSC)国家许可条款国家许可条款监管事务 监管事务风险 - 收益关系未经证实的细胞和基因干预.更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.3K
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
1.2K
相关概念视频
Standards of Care II
641
Nurses bear specific legal responsibilities under several federal statutes, including:
641
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
